Iovance Biotherapeutics Inc. Common Stock vs Lattice Semiconductor Corporation Common Stock — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $13.44 (market cap $5.85B), while Lattice Semiconductor Corporation Common Stock trades at $127.84 (market cap $18.61B). The key difference: Lattice Semiconductor Corporation Common Stock is far larger — about 3.2× Iovance Biotherapeutics Inc. Common Stock's market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, Lattice Semiconductor Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Lattice Semiconductor Corporation Common Stock for 0 Days on average.
| IOVA | LSCC | |
|---|---|---|
Market Cap | $5.85B | $18.61B |
Volume | 14,517,176 | 1,778,419 |
Sector | Health | Technology |
52-Week High | $14.82 | $155.27 |
52-Week Low | $1.81 | $61.73 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.78B | $18.48B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →Lattice Semiconductor develops low-power programmable chips, known as FPGAs. Its products are used in communications, computing, industrial, and automotive applications.
Read more on LSCC →